Log in

Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Scutellarin, a flavonoid glycoside, is the primary active ingredient in breviscapine that is a mixture of flavonoid glycosides extracted from a Chinese herbErigeron breviscapus (Vant.) Hand.-Mazz. The pharmacokinetics of scutellarin and its aglycone conjugated metabolites after intraperitoneal injection and oral administration of breviscapine was investigated in rats. The plasma concentration of scutellarin and scutellarein conjugates in serial samples was measured by validated high-performance liquid chromatography methods. The pharmacokinetic results indicated that scutellarin underwent rapid and extensive biotransformationin vivo. After intraperitoneal injection, scutellarin was absorbed rapidly. The profiles of scutellarin and scutellarein conjugates were fitted to a two-compartment open model. Scutellarin and scutellarein conjugates showed a similar time course. No significant difference in tmax, t0.5(α) and t0.5(β) was observed between scutellarin and scutellarein conjugates (p>0.05). After oral administration, fluctuations were observed in the concentration-time profiles of both scutellarin and scutellarein conjugates and the pharmacokinetics could not be explained by classical compartment model. The relative bioavailability of oral administration was very low, 10.67 %±4.78 % for scutellarin and 7.92 %±1.90 % for scutellarein conjugates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Xu J.M., Huang Z.H. (1991): DengZhan ****n capsules in the treatment of cerebrovascular disorders in 74 patients. Chin. J. New Drugs Clin. Rem., 10, 260–263.

    Google Scholar 

  2. Xu Q.Y., Li X.X. (1995): Influences of DengZhan ****n injection on blood viscosity in patients with high blood viscosity. Chin. J. New Drugs Clin. Rem., 14, 233–235.

    Google Scholar 

  3. Zhang J., Li X.S., Zhang W.D. (2002): The advance in studies on chemical component and pharmacology of Erigeron breviscapus. J. Pharm. Pract., 20, 103–107.

    Google Scholar 

  4. Hong H., Liu G.Q. (2004): Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci., 74, 2959–2973.

    Article  CAS  PubMed  Google Scholar 

  5. Lai M.Y., Hsiu S.L., Tsai S.Y., Hou Y.C., Chao P.D.L. (2003): Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. J. Pharm. Pharmacol., 55, 205–209.

    Article  CAS  PubMed  Google Scholar 

  6. Lai M. Y., Hsiu S.L., Chen C.C., Hou Y.C., Chao P.D.L. (2003): Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of scutellariae radix in humans. Biol. Pharm. Bull., 26, 79–83.

    Article  CAS  PubMed  Google Scholar 

  7. Hsiu S.L., Huang T.Y., Hou Y.C., Chin D.H., Chao P.D.L. (2002): Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci., 70, 1481–1489.

    Article  CAS  PubMed  Google Scholar 

  8. Kabaze F.I., Kokkalou E., Georgarakis M., Niopas I. (2004): Validated high-performance liquid chromatographic method utilizing solid-phase extraction for the simultaneous determination of naringenin and hesperetin in human plasma. J. Chromatogr. B, 801, 363–367.

    Article  Google Scholar 

  9. Akao T., Kawabata K., Yanagisawa E., Ishihara K., Mizuhara Y., Wakui Y., Sakashita Y., Kobashi K. (2000): Baicalin, the predominant flavone glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol., 52, 1563–1568.

    Article  CAS  PubMed  Google Scholar 

  10. Muto R., Motozuka T., Nakano M., Tatsumi Y., Sakamoto F., Kosaka N. (1997): The chemical structure of new substance as the metabolite of baicalin and time profiles for the plasma concentration after oral administration of sho-saiko-to in human. Yakugaku Zasshi, 118, 79–87.

    Google Scholar 

  11. Shimoi K., Okada H., Furugori M., Goda T., Takase S., Suzuki M., Hara Y., Yamamoto H., Kinae N. (1998): Intestinal absorption of luteolin and luteolin 7-O-β-glucoside in rats and humans. FEBS Lett., 438, 220–224.

    Article  CAS  PubMed  Google Scholar 

  12. Murota K., Terao J. (2003): Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys., 417, 12–17.

    Article  CAS  PubMed  Google Scholar 

  13. Yang Q., Yang J.Y., Li S.C., Zhang L.M. (2004): The relative bioavailability of breviscapine sustained-release tablets in beagle dogs. West China J. Pharm. Sci., 19, 175–178.

    CAS  Google Scholar 

  14. Liu Y.M., Lin A.H., Chen H., Zeng F.D. (2003): Study on pharmacokinetics of scutellarin in rabbits. Acta. Pharm. Sin., 38, 775–778.

    CAS  Google Scholar 

  15. Jiang X.H., Li S.H., Lan K., Yang J.Y., Zhou J. (2003): Study on the pharmacokinetics of scutellarin in dogs. Acta. Pharm. Sin., 38, 371–373.

    Google Scholar 

  16. Li S.H., Jiang X.H., Lan K., Yang J.Y., Zhou J. (2003): Pharmacokinetics of scutellarin in dogs. J. Chin. Pharm. Sci., 12, 127–130.

    CAS  Google Scholar 

  17. Ge Q.H., Zhou Z., Zhi X.J., Ma L.L., Chen X.H. (2003): Pharmacokinetics and absolute bioavailability of breviscapine in beagle dogs. Chin. J. Pharm., 34, 618–620.

    CAS  Google Scholar 

  18. Li S.H., Jiang X.H., Yang Q., ** C.H. (2003): Pharmacokinetics of scutellarin in rabbits. J. Biomed. Eng., 20, 692–694.

    CAS  Google Scholar 

  19. Zhang J.L., Che Q.M., Li S.Z., Zhou T.H. (2003): Study on metabolism of scutellarin in rats by HPLC-MS and HPLC-NMR. J. Asian. Nat. Prod. Res., 5, 249–256.

    Article  CAS  PubMed  Google Scholar 

  20. Wang H., Chen J.M., Zhang Q.M. (2000): A study on the absorption kinetics of baicalin in rats’ stomachs and small intestines in vitro. J. Shenyang Pharm. Univ., 17, 5–7.

    CAS  Google Scholar 

  21. Ding J.S., Zhang J.S. (2003): Absorption of breviscapine in small intestine of rat. J. Chin. Pharm. Univ., 34, 65–69.

    CAS  Google Scholar 

  22. Murota K., Shimizu S., Chujo H., Moon J.H., Terao J. (2000): Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch. Biochem. Biophys., 384, 391–397.

    Article  CAS  PubMed  Google Scholar 

  23. Nemeth K., Plumb G.W., Benin J.G., Juge N., Jacob R., Nairn H.Y., Williamson G., Swallow D.M., Kroon P.A. (2003): Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur. J. Nutr., 42, 29–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, J.M., Weng, W.Y., Huang, X.B. et al. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats. European Journal of Drug Metabolism and Pharmacokinetics 30, 165–170 (2005). https://doi.org/10.1007/BF03190615

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190615

Keywords

Navigation